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Objective: To evaluate the in vitro cytotoxic activity of the fractionated extract as well as
isolated compounds of Arum palaestinum Boiss. (A. palaestinum) (black calla lily), and to
identify the volatile components which may be responsible for the potential antitumor
activity.
Methods: A. palaestinum was collected from its natural habitats and subjected to
phytochemical analysis for separation of pure compounds. In vitro cytotoxic activity was
investigated against four human carcinoma cell lines Hep2, HeLa, HepG2 and MCF7 for
the fractionated extract and isolated compounds. While, the diethyl ether fraction was
subjected to GC–MS analysis as it exhibited the most potent cytotoxic effect to evaluate
the active constituents responsible for the cytotoxic activities.
Results: Four ﬂavonoid compounds were isolated (luteolin, chrysoeriol, isoorientin,
isovitexin) from the diethyl ether and ethyl acetate. The extracts and the pure isolated
compounds showed a signiﬁcant high antiproliferative activity against all investigated cell
lines. The GC–MS analysis revealed the separation and identiﬁcation of 15 compounds
representing 95.01% of the extract and belonging to different groups of chemical
compounds.
Conclusions: The present study is considered to be the ﬁrst report on the cytotoxic
activities carried out on different selected fractions and pure compounds of
A. palaestinum to provide evidences for its strong antitumor activities. In addition,
chrysoeriol and isovitexin compounds were isolated for the ﬁrst time from the studied
taxa.1. Introduction
Arum L. is a genus of ﬂowering plants belonging to family
Araceae, represented by 26 species and distributed in Northern
Africa, Mediterranean Region, Western Asia, and Europe [1].
Arum palaestinum Boiss. (A. palaestinum), known as black
calla lily, it is edible and considered as ornamental plant, and
used in folk medicine to cure several chronic diseases such asstomach acidity, atherosclerosis, cancer and diabetes [2,3]. The
preservation and conservation of A. palaestinum were carried
out by Shibli et al. and Farid et al. [4,5].
A few publications are about the phytochemical investigation
and biological activity of A. palaestinum. It is characterized by
presence of alkaloids, proanthocyanidins, ﬂavones and their C-
glycosides and ﬂavonols [6,7]. A comprehensive metabolite
proﬁling of A. palaestinum leaves by using liquid
chromatography tandem mass spectrometry was studied by
Abu-Reidah et al. [8]. It is worth to mention that in all
published reports of its phytochemical studies, leaves and
ﬂowers of A. palaestinum were used and evidences for strong
antitumor activities of its extracts and isolated compounds
were provided [1,9].pen access article under the CC BY-NC-ND
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activity of the fractionated extract as well as isolated compounds
of A. palaestinum against four human carcinoma cell lines Hep2,
HeLa, HepG2 and MCF7, and to identify the volatile compo-
nents which may be responsible for the potential antitumor ac-
tivity by using gas chromatography–mass spectrometry (GC–
MS) through preliminary analysis.
2. Materials and methods
2.1. Plant collection
A. palaestinum Boiss. was collected from their growing
habitats in Bergesh protected area, Irbid, Jordan (latitude:
3225043.168200 N and longitude: 3546047.009400 E) in
February 2012 by Dr. Ahmed El-Oqlah, Department of Bio-
logical Sciences, Yarmouk University, Jordan.
2.2. Extraction and isolation
The aerial parts of A. palaestinum were air dried and ground
in the laboratory, and the obtained powder (1 450 g) was
extracted three times at room temperature with 70% methanol
for an interval of six days. The aqueous-methanol extract was
evaporated under reduced pressure and temperature to obtain a
residue of 302 g. The residue was dissolved in distilled water
(500 mL) and fractionated by using diethyl ether (44 g),
dichloromethane (26 g), ethyl acetate (40 g), butanol (75 g),
methanol (56 g) and water (58 g) according to their polarity, then
the fractions were subjected to biological analysis. Diethyl ether
and ethyl acetate fractions were subjected to 3 mm paper chro-
matography by using bulk acoustic wave as eluent to yield
compound 1 (7.0 mg), compound 2 (3.8 mg), and compound 3
(3.5 mg) from the diethyl ether fraction; and compound 4
(4.3 mg) was isolated from the ethyl acetate fraction. Each in-
dividual compound was subjected to a Sephadex LH-20 column
for the ﬁnal puriﬁcation.Table 1
IC50 of the antitumor activity of fractionated extract and pure compounds
of A. palaestinum against the four carcinoma cell lines. mg/mL.
Extract IC50
Hep2 HeLa HepG2 MCF7
Crude extract 23.60 23.90 14.20 17.80
Diethyl ether fraction 3.83 4.13 3.68 3.53
Dichloromethane fraction 10.30 11.30 8.63 6.23
Ethyl acetate fraction 33.80 31.90 12.50 27.20
Methanol fraction 38.90 29.50 15.20 28.40
Water fraction 22.70 18.80 19.60 26.90
Luteolin 9.98 16.00 17.80 21.80
Chrysoeriol 12.20 16.40 23.00 18.20
Isoorientin 18.80 32.30 20.00 19.90
Isovitexin 22.70 20.50 21.70 18.50
Doxorubicin standard 3.73 4.19 4.28 4.432.3. Structure elucidation of the isolated compounds
The identiﬁcation of compounds was determined by Rf
values, color reactions, ultraviolet spectrophotometry, 1D-NMR
spectroscopy, and electron impact ion source/mass spec-
trometery. Trace compounds were identiﬁed by co-
chromatography with reference samples which were obtained
from Department of Phytochemistry and Plant Systematics,
National Research Center, Egypt.
2.4. Cell culture and in vitro cytotoxic activity
Four human tumor cell lines, epidermal carcinoma of larynx
(Hep2), cervix (HeLa), liver (HepG2) and breast (MCF7) were
used in the study and obtained from the American Type Culture
Collection, Minisota, USA. The cell lines were maintained at the
National Cancer Institute, Cairo, Egypt, by serial subculturing.
The samples were prepared by dissolving 1:1 stock solution in
dimethylsulfoxide at 100 mmol/L and stored at −20 C.
The cytotoxic activity of the fractionated extract and pure
compounds were carried out by using sulforhodamine-B (SRB)
assay following the method reported by Vichai and Kirtikara [10].
SRB is a bright pink aminoxanthrene dye with two sulphonicgroups. It is a protein stain that binds to the amino groups of
intracellular proteins under mildly acidic conditions to provide a
sensitive index of cellular protein content. Cells were seeded in
96-well microtiter plates at initial concentration of 3 × 103 cell/
well in a 150 mL fresh medium for 24 h before treatment with the
extract to allow attachment of cells to the wall of the plate. The
extract as well as pure compounds at different concentrations
(0.0, 5.0, 12.5, 25.0 and 50.0 mg/mL) were added to the cell
monolayer in triplicate. Monolayer cells were incubated with the
compounds for 48 h at 37 C in an atmosphere of 5% CO2. After
48 h, cells were ﬁxed, washed and stained with SRB. Excess
stain was washed with acetic acid and attached stain was
recovered with ethylenediaminetetraacetic acid–Tris buffer.
Color intensity was measured at 570 nm with an ELISA reader.
The relation between surviving fraction and drug concentration
was plotted to obtain the survival curve of each tumor cell line as
compared with doxorubicin, the control anticancer drug.2.5. GC–MS
GC–MS analysis was performed on a thermo scientiﬁc
TRACE GC ultra gas chromatograph directly coupled to ISQ
single quadrupole mass spectrometer, by using non-polar 5%
phenyl methylpolysiloxane capillary column (30.00 m ×
0.25 mm × 0.25 mm) type TG-5MS under the following con-
ditions: oven temperature program from 60 C (3 min) to 280 C
at 5 C/min, then isothermal at 280 C for 5 min. The carrier gas
was helium at ﬂow rate of 1 mL/min. The volume of injected
sample was 1 mL of sample in diethyl ether using splitless in-
jection technique, ionization energy 70 eV, in the electronic
ionization mode. The identiﬁcation of the compounds were
carried out by matching their fragmentation patterns in mass
spectra with those in Wiley Registry 9th and NIST11 GC–MS
libraries.
3. Results
3.1. Structure elucidation of the isolated compounds
The present work dealed with the isolation and character-
ization of four compounds: luteolin (Compound 1), chrysoeriol
(Compound 2), isoorientin (Compound 3), isovitexin (Com-
pound 4). Compounds 2 and 4 were isolated for the ﬁrst time
from the studied taxa.
Figure 1. Cytotoxic activity of standard doxorubicin (A), diethyl ether
extract (B), dichloromethane (C) and ethyl acetate (D) extract of
A. palaestinum against different carcinoma cell lines (Hep2, HeLa, HepG2,
MCF7).
Figure 2. Cytotoxic activity of pure compounds luteolin (A), chrysoeriol
(B), isoorientin (C), and isovitexin (D) isolated from A. palaestinum against
different carcinoma cell lines (Hep2, HeLa, HepG2, MCF7).
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The in vitro cytotoxicity of the fractionated extract and the
isolated compounds of A. palaestinum showed its signiﬁcantTable 2
GC–MS analysis of diethyl ether fraction of A. palaestinum.
No. Compound Molecular weig
1 Butylated hydroxytoluene 220
2 Dihydroactinidiolide 180
3 3-Buten-2-one,4-(4-OH-2,2,6 tri-OCH3-7oxa
bicyclo[4.1.0]hept-1-yl)
224
4 (−)-Loliolide 196
5 Pluchidiol 208
6 Hexahydrofarnesyl acetone 268
7 Hexadecanoic acid, methyl ester 270
8 Linoleic acid, methyl ester 294
9 Linolenic acid, methyl ester 292
10 Phytol 296
11 Phytol acetate 338
12 1-mono linolenin 352
13 Cholestan-3-one,cyclic-1,2-ethanediyl aetal,(5a´) 430
14 Bis (2-ethylhexyl) phthalate 390
15 Quercetin 7,30,40-tri-OCH3 344antitumor activity against the four cell lines Hep2, HeLa, HepG2
and MCF7 (Table 1, Figures 1 and 2).
The results suggested that diethyl ether fraction exhibited
obviously higher antiproliferative activity compared with the
regular regimen for cancer treatment in which doxorubicin was
used as a protocol even in a relatively low dose of IC50 of 3.83,
4.13, 3.68, and 3.53 against Hep2, HeLa, HepG2 and MCF7 cell
lines, respectively. Also, dichloromethane fraction revealed
strong activity against all tested cell lines with IC50 of 10.30,
11.30, 8.63, and 6.23, respectively.
The four isolated ﬂavonoid compounds (luteolin, chrysoeriol,
isoorientin, isovitexin) were tested against the four cell lines and
showed moderate antitumor activity in comparison with isolated
fractions (Table 1, Figure 2).
3.3. GC–MS analysis
The diethyl ether fraction of A. palaestinum was subjected to
GC–MS analysis to identify the volatile constituents and com-
pounds of which are biologically active. A total of 15 com-
pounds were identiﬁed and represented 95.01% of the extract
(Table 2). The most important compounds were phytol, phytol
acetate, linolenic, linoleic and hexadecanoic acid which repre-
sented by 25.29%, 5.05%, 22.37%, 6.54% and 21.89% respec-
tively, of the total extract. These compounds may be responsible
for the higher anticancer activity of diethyl ether fraction.
4. Discussion
The cytotoxicity results suggested that the diethyl ether
fraction exhibited an obviously higher antiproliferative activity
compared with the regular regimen for cancer treatment in which
doxorubicin was used as a protocol even in a low dose. The
obtained results are in agreement with previous studies which
showed that luteolin and isoorientin have antimutagenic activity
on different cell lines [11]. In addition, isovitexin has an effect on
reducing inﬂammation and carcinogenesis [12]. To our
knowledge, there are no previous data recorded on the
antitumor activity of chrysoeriol. From GC–MS data, phytol is
a major compound with a cytotoxic activity against some cell
lines [13]. It was reported that phytol acetate had antimicrobial,
anti-inﬂammatory, anticancer and antidiuretic properties [14].ht Retention time (min) Relative area (%) Molecular formula
20.42 1.61 C15H24O
20.79 0.76 C11H16O2
22.84 1.41 C13H20O3
23.90 0.79 C11H16O3
24.12 1.03 C13H20O2
24.56 4.50 C18H36O
25.42 21.89 C17H34O2
27.10 6.54 C19H34O2
27.18 22.37 C19H32O2
27.29 25.29 C20H40O
28.21 5.05 C22H42O2
29.28 1.39 C21H36O4
29.46 0.68 C29H50O2
31.06 1.27 C24H38O4
40.58 0.43 C181H16O7
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belong to the u3 and u6 fatty acids respectively, while
hexadecanoic acid is saturated fatty acid. These fatty acids
have recently drawn attention and are recently marketed as
health supplements; their methyl ester derivatives are of much
biological importance, and they have antioxidant, anticancer
and antihistaminic properties [15].
The present study is considered to be a preliminary investi-
gation for future development of naturally occurring antitumor
drugs, though some synergistic or antagonistic effects needed to
be clariﬁed. The underlying antitumor mechanism of
A. palaestinum fractionated extract and the isolated compounds
as well as preparation in a large scale also need to be further
studied.
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